Clinical Trials in Nashville

Showing 1121-1140 of 20,298 trials

A Study of ZL-1310 in Participants With Selected Solid Tumors

NCT06885281

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Zai Lab (Shanghai) Co., Ltd.112 participantsStarted May 2025

San Francisco, California, United States • Detroit, Michigan, United States • New York, New York, United States +17 more locations

Active Not RecruitingNA< 1 mile

CHAMPION-AF Clinical Trial

NCT04394546

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

Atrial FibrillationStrokeBleeding

Boston Scientific Corporation3,000 participantsStarted Oct 2020

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +138 more locations

A Study of ZL-1310 in Participants With Selected Solid Tumors

CHAMPION-AF Clinical Trial

Find Trials by Condition in Nashville

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

Understanding Needs of Older Patients Prior to Starting Cancer Treatment

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

PV Loop & Coarctation Study

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections